Data as of Aug 25, 2026 · Based on 2,004 AI responses · See how Parse measures this
Clinical Trial Operations Platforms
Parse
https://parse.gl
Medidata currently holds the top position in the clinical trial operations platform niche, driven by its frequent recommendations for enterprise data integration and decentralized trial execution. Meanwhile, specialized tools like and secure strong secondary positions by dominating specific operational workflows like risk-based monitoring and hybrid study designs.
| # | Brand | What AI says | Mention rate |
|---|---|---|---|
| 1 | Frequent recommendation for enterprise EDC integration and automated site payments. | 26% | |
| 2 | Recommended for unified clinical ecosystems and automated milestone payments. | 20% | |
| 3 | 19% | ||
| 4 | Standard recommendation for detailed preregistration templates across study designs. | 15% | |
| 5 | 14% | ||
| 6 | 13% | ||
| 7 | Preferred for rapid, minimalist preregistration of simple experimental studies. | 13% | |
| 8 | Recommended for patient-centric decentralized trials with native home health integration. | 10% | |
| 9 | Highlighted for hybrid decentralized trials and API-first data capture. | 10% | |
| 10 | 8% | ||
| 11 | 7% | ||
| 12 | Noted for aggregating multi-CRO data into unified portfolio health dashboards. | 6% | |
| 13 | 6% | ||
| 14 | 6% | ||
| 15 | 6% | ||
| 16 | 6% | ||
| 17 | 6% | ||
| 18 | 6% | ||
| 19 | 5% | ||
| 20 | 5% | ||
| 21 | 5% | ||
| 22 | 5% | ||
| 23 | 5% | ||
| 24 | 5% | ||
| 25 | 4% |
Who wins on each AI
The same market, seen by two models.
Sources AI cited
pmc.ncbi.nlm.nih.gov is the page AI reaches for most here, cited in 20% of analyzed answers.
“established enterprise platform” → “data-driven monitoring and financial automation ecosystem”
Emerging in ChatGPT responses in Apr 2026 as a pure-play DCT platform
Cited in Google AI Overviews in Apr 2026 for RAG-based regulatory alignment
| Brand | ChatGPT Search | Google AI Mode | Comparison |
|---|---|---|---|
| 11% | 18% | ||
| 17% | 9% | ||
| 14% | 15% | ||
| 16% | 14% | ||
| 15% | 0% |
The two models disagree most about RealTime eClinical Solutions (ChatGPT #11, Google #1) and Oracle (ChatGPT #4, Google #13).
Between Apr 23 and Apr 24, ChatGPT and Google AI Overviews shifted from listing general DCT software to distinguishing between platform-first software and CRO-led execution models. Medable and
Castor EDC emerged as the primary software recommendations for native eConsent and home health integration.
Brands mentioned
I need a decentralized clinical trial platform that supports eConsent and home health visits.
Between Apr 23 and Apr 24, ChatGPT and Google AI Overviews shifted from listing general DCT software to distinguishing between platform-first software and CRO-led execution models. Medable and
Castor EDC emerged as the primary software recommendations for native eConsent and home health integration.
Across both platforms in April 2026, responses uniformly identified RTSM and IRT systems as the standard for tracking drug kit inventory and preventing stockouts. AI models emphasized predictive forecasting and automated resupply triggers over manual inventory checks.
View promptAcross both platforms in April 2026, responses uniformly identified RTSM and IRT systems as the standard for tracking drug kit inventory and preventing stockouts. AI models emphasized predictive forecasting and automated resupply triggers over manual inventory checks.
Medidata currently holds the top position in the clinical trial operations platform niche, driven by its frequent recommendations for enterprise data integration and decentralized trial execution. Meanwhile, specialized tools like Castor EDC and CluePoints secure strong secondary positions by dominating specific operational workflows like risk-based monitoring and hybrid study designs.
Across 2,004 AI responses, Medidata is mentioned most, named in 26% of them, followed by Veeva (20%) and RealTime eClinical Solutions (19%).
Parse measures each brand's mention rate — the share of answers naming it — across 2,004 AI responses to this market's buyer questions. Answers are collected daily and the ranking is published weekly.
Brands enter the ranking when AI answers mention them. Parse collects answers daily and publishes the re-measured set weekly, so new brands appear as AI starts recommending them.
The market map
Recommended by need